Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Nov 13, 2026
Reporting period
Not applicable
Filed with the SEC
Nov 17, 2026
CEOIndirect holdingGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000950142-26-003103
Filed / recorded
Nov 17, 2026, 10:02 PM UTC
Added to OQRO
Nov 17, 2026, 10:06 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Medicus Pharma Ltd.
Issuer CIK
1997296
Ticker
MDCX
Reporting person
Raza Bokhari
Relationship
Director, Officer, 10% owner
Officer title
Chief Executive Officer
Security
Common Shares, no par value
Table
Non-derivative (Table I)
Transaction date
Nov 13, 2026
Transaction code
A
Shares / units
436,046
Price per share
$1.72
Acquired / disposed
Acquired (A)
Shares owned after
451,909
Ownership form
Indirect — See Footnote
Amendment
No
Footnotes from the filing
On November 13, 2026, RBx Capital, LP, an entity controlled by Dr. Raza Bokhari, entered into a subscription agreement with the Issuer, pursuant to which RBx Capital, LP agreed to purchase 436,046 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.
Held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.